Rise Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Rise Therapeutics's estimated annual revenue is currently $3.3M per year.
- Rise Therapeutics's estimated revenue per employee is $155,000
- Rise Therapeutics's total funding is $0.4M.
Employee Data
- Rise Therapeutics has 21 Employees.
- Rise Therapeutics grew their employee count by 5% last year.
Rise Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP, Development and Manufacturing | Reveal Email/Phone |
3 | Clinical Scientist | Reveal Email/Phone |
Rise Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Rise Therapeutics?
Rise Therapeutics is developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. The company develops unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity and cancer.
keywords:N/A
$0.4M
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 21 | -5% | N/A |
#2 | $2.1M | 21 | -9% | N/A |
#3 | $4.3M | 21 | 133% | N/A |
#4 | $2.2M | 22 | 10% | N/A |
#5 | $3.2M | 22 | 10% | N/A |